Home           |           About Us           |           Register Free           |           Events and Conferences           |           Contact Us

EntreMed Inc. has raised $20 million in financing from three major financial companies to help fund clinical work for the next two years.

The Rockville pharmaceutical company, which develops treatment for cancer and inflammatory diseases, said Monday it closed the secured loan agreement with GE Healthcare Financial Services, Merrill Lynch Capital and Oxford Finance Corp.

A virus used in a gene therapy experiment likely didn't cause the death of an Illinois woman suffering from rheumatoid arthritis, although it can't be completely ruled out, government health advisers said Monday.

Advisers to the National Institutes of Health said that a massive fungal infection is near the top of the list of likely culprits in the death of Jolee Mohr.

11 September 2007

Cognos Clinical Trial Enrollment Forecasting Blueprint offers flexible patient enrollment modeling and analytics, enabling managers to track enrollment progress, success of costly studies

2007 CLINICAL PERFORMANCE METRICS SUMMIT, Philadelphia, PA September 11, 2007– Cognos (NASDAQ: COGN; TSX: CSN), the world leader in business intelligence and performance management solutions, continues to extend its pharmaceutical market leadership, announcing today the launch of a new performance solution designed to help pharmaceutical companies better anticipate and manage patient enrollment requirements to ensure clinical trials successfully comply with FDA requirements.

The Middle East market for pharmaceutical manufacturing and biotechnology, already valued at over USD 28 billion and with annual growth in double digits, looks set for even stronger growth as some of the world's major players eye the regional market, according to the organisers of the region's premier industry event - Pharmaceutical Manufacturing and Biotechnology Middle East (PABME).